Genomics Market Size, Share, Trends & Growth Report 2023-28

IMARC Group, a leading market research company, has recently releases report titled “Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global genomics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report HighlightsHow big is the genomics market?The global genomics market size reached US$ 29.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 68.8 Billion by 2028, exhibiting a growth rate (CAGR) of 15% during 2023-2028.What is genomics?Genomics is the study of the structure of the genome that contains non-coding DNA, genes, chloroplast, and mitochondrial DNA. It is employed to prevent, manage, and treat diseases. Genomics aims to understand the mapping of the genes and sequence the DNA by examining the molecular mechanisms and the interplay of genetic and environmental factors in diseases. Genomics is also instrumental in solving complex genetic problems, and the examination of the biological functions of individual genes is a common process in medical and biological research. As a result, genomics finds application in diagnostics, drug discovery, development of precision medicine, and agricultural research.Request for a sample copy of this report: are the growth prospects and trends in the genomics industry?The market is primarily driven by the growing demand for personalized medicine to provide effective treatment. Genomics is also used in the agricultural sector to produce genetically modified (GM) plants and organisms. Besides this, the introduction of microarrays and DNA technologies backed by genomics is attracting extensive investment from government and private agencies. Along with this, governments of various countries are promoting research and development activities in the field of genomics, which, in turn, is providing a favorable market outlook. In addition to this, the rising incidences of chronic diseases and cancer have resulted in the growing adoption of non-invasive cancer screening-based research, thereby propelling the market growth. Moreover, the advent of next-generation sequencing technology has enabled the development of life-science databases and projects to support scientific research, which is propelling the market growth. Looking forward, the market is expected to grow at a CAGR of 15% during the forecast period (2023-2028).What is included in market segmentation?The report has segmented the market into the following categories:Breakup by Component:

  • Products
    • Instruments and SoftwareConsumables and Reagents
    • Core Genomics ServicesNGS-Based ServicesBiomarker Translation ServicesComputational ServicesOthers
  • Breakup by Application:
  • Functional GenomicsEpigenomicsBiomarkers DiscoveryPathway AnalysisOthers
  • Breakup by Technology:
  • SequencingMicroarrayPolymerase Chain ReactionNucleic Acid Extraction and PurificationOthers
  • Breakup by End-User:
  • Research CentersHospitals and ClinicsPharmaceutical and Biotechnology CompaniesOthers
  • Breakup by Region:North America: (United States, Canada)Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)Latin America: (Brazil, Mexico, Others)Middle East and AfricaWho are the key players operating in the industry?The report covers the major market players including:
  • 23andMe, IncAgilent Technologies, Inc.Bayer AGBGI GroupBio-Rad Laboratories, Inc.Danaher CorporationIllumina, Inc.Oxford Nanopore TechnologiesPerkinElmer, Inc.Myriad Genetics, Inc.Hoffmann-La Roche LtdThermo Fisher Scientific Inc
  • Ask Analyst for Customization and Browse full report with TOC & List of Figure: you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.About UsIMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.Contact USIMARC Group134 N 4th St. Brooklyn, NY 11249, USAUSA: +1-631-791-1145 | Asia: +91-120-433-0800Email: sales@imarcgroup.comFollow us on Twitter: @imarcglobalLinkedIn: 

    Leave a Reply

    Your email address will not be published. Required fields are marked *